# US 2012/0252032 A1 · Immunoassay Device with Improved Sample Closure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252032 A1
- Document ID: US20120252032A1
- Status: Published application
- Kind: A1
- Application number: 13/492,089
- Filed: 2012-06-08
- Published: 2012-10-04
- Earliest claimed: 2003-09-10
- Assignees: Abbott Point of Care Inc.
- Inventors: Cary James Miller; Andy Maczuszenko
- Web page: https://patentgrep.com/patent/US20120252032A1

## CPC

- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- B01L 3/502707: {characterised by the manufacture of the container or its components}
- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- B01L 3/502723: {characterised by venting arrangements}
- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- B01L 3/502738: {characterised by integrated valves (throttle valves in microfluidic sample containers B01L3/502746)}
- B01L 2200/0689: Sealing
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2300/045: whereby the whole cover is slidable
- B01L 2300/0645: Electrodes
- B01L 2300/069: Absorbents; Gels to retain a fluid
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/087: Multiple sequential chambers
- B01L 2400/046: Chemical or electrochemical formation of bubbles
- B01L 2400/0481: squeezing of channels or chambers
- B01L 2400/0487: fluid pressure, pneumatics
- B01L 2400/0683: mechanically breaking a wall or membrane within a channel or chamber
- B01L 2400/0688: surface tension valves, capillary stop, capillary break
- G01N 31/22: using chemical indicators (G01N31/02 takes precedence)
- Y10T 436/25: including sample preparation
- Y10T 436/2575: Volumetric liquid transfer
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

An apparatus and method for sealing a fluid sample collection device, comprising loading a fluid sample collection device with a fluid sample, said device comprising a housing having at least one substantially planar surface that includes an orifice in fluid communication with an internal fluid sample holding chamber which terminates at an internal capillary stop; and slidably moving a sealing element over at least a portion of said substantially planar surface in a way that displaces any excess fluid sample away from the orifice, seals the fluid sample within said holding chamber, and inhibits the fluid sample from prematurely breaking through the internal capillary stop.

## Claims

### Claim 1

A device configured to receive whole-blood, comprising:
a conduit that is in part corona-treated and in part coated with a dry reagent mixture comprising at least a water-soluble protein and a polymer containing hydroxyl groups.

### Claim 2 (depends on 1)

The device of claim 1, wherein the conduit is configured to terminate at an internal capillary stop.

### Claim 3 (depends on 2)

The device of claim 2, further comprising a pump configured to displace the whole-blood past the internal capillary stop and throughout the device.

### Claim 4 (depends on 3)

The device of claim 3, wherein the pump is an airbladder.

### Claim 5 (depends on 1)

The device of claim 1, further comprising a pump configured to dissolve and concentrate the dry reagent mixture in a segment of the whole-blood.

### Claim 6 (depends on 5)

The device of claim 5, wherein the pump is an airbladder.

### Claim 7 (depends on 1)

The device of claim 1, wherein the conduit is further in part coated with a dry reagent composition comprising an additive selected from the group consisting of: goat IgG, mouse IgG, heparin, dextran, Tris buffer, proclin, and sodium chloride in a support matrix.

### Claim 8 (depends on 7)

The device of claim 7, wherein the support matrix is cellulose, polyvinyl alcohol, gelatin, or mixtures thereof.

### Claim 9 (depends on 7)

The device of claim 7, wherein the dry reagent composition is located on a part of the conduit such that the dry reagent composition is introduced to a segment of the whole-blood prior to a whole-blood immunoassay.

### Claim 10 (depends on 9)

The device of claim 9, further comprising a pump configured to dissolve and concentrate the dry reagent composition in the segment of the whole-blood.

### Claim 11 (depends on 1)

The device of claim 1, wherein the conduit is further in part coated with a dry reagent composition comprising an additive selected from the group consisting of: dextran and sodium chloride in a support matrix.

### Claim 12 (depends on 11)

The device of claim 11, wherein the support matrix is cellulose, polyvinyl alcohol, gelatin, or mixtures thereof.

### Claim 13 (depends on 11)

The device of claim 11, wherein the dry reagent composition is located on a part of the conduit such that the dry reagent composition is introduced to a segment of the whole-blood prior to a whole-blood immunoassay.

### Claim 14 (depends on 13)

The device of claim 13, further comprising a pump configured to dissolve and concentrate the dry reagent composition in the segment of the whole-blood.

### Claim 15 (depends on 1)

The device of claim 1, wherein the dry reagent mixture further comprises bovine serum albumin (BSA).

### Claim 16 (depends on 1)

The device of claim 1, wherein the dry reagent mixture further comprises bovine serum albumin (BSA), glycine, a polyethylene glycol (PEG), and a sugar.

### Claim 17

A dry reagent composition configured as a solute to be dissolved into whole-blood prior to a whole-blood immunoassay, the dry reagent composition comprising: goat IgG, mouse IgG, heparin, dextran, Tris buffer, proclin, and sodium chloride in a support matrix.

### Claim 18 (depends on 17)

The dry reagent composition of claim 17, wherein the support matrix is cellulose, polyvinyl alcohol, gelatin, or mixtures thereof.

### Claim 19 (depends on 17)

The dry reagent composition of claim 17, wherein the dry reagent composition includes sodium azide and Tween 20.

### Claim 20

A dry reagent composition configured as a solute to be dissolved into whole-blood prior to a whole-blood immunoassay, the dry reagent composition comprising dextran and sodium chloride in a support matrix.
